Science Daily: Pharmacology News
FEBRUARY 25, 2024
A drug that binds to allergy-causing antibodies can protect children from dangerous reactions to accidentally eating allergy-triggering foods, a new study found.
SCIENMAG: Medicine & Health
FEBRUARY 25, 2024
ANN ARBOR, Mich. – While it’s not surprising to spot teens wearing headphones and earbuds, it’s also becoming a widespread trend among younger children, a national poll suggests. Credit: University of Michigan Health C.S. Mott Children’s Hospital National Poll on Children’s Health ANN ARBOR, Mich.
Drug Patent Watch
FEBRUARY 25, 2024
This chart shows the pharmaceutical companies with the most patents in Serbia. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is… The post Which pharmaceutical companies have the most drug patents in Serbia? appeared first on DrugPatentWatch - Make Better Decisions.
Covalent Modifiers
FEBRUARY 25, 2024
Gan-Qiang Lai, Yali Li, Heping Zhu, Tao Zhang, Jing Gao, Hu Zhou and Cai-Guang Yang RSC Chem. Biol. , 2024 , DOI: 10.1039/D3CB00230F N6-Methyladenosine (m6A) is the most prevalent mRNA modification and is required for gene regulation in eukaryotes. ALKBH5, an m6A demethylase, is a promising target, particularly for anticancer drug discovery. However, the development of selective and potent inhibitors of ALKBH5 rather than FTO remains challenging.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Drug Patent Watch
FEBRUARY 25, 2024
Annual Drug Patent Expirations for NASCOBAL Nascobal is a drug marketed by Par Pharm and Endo Pharms Inc and is included in two NDAs. It is available from one supplier.… The post New patent expiration for Endo Pharms drug NASCOBAL appeared first on DrugPatentWatch - Make Better Decisions.
ProRelix Research
FEBRUARY 25, 2024
The role of Real-World Evidence (RWE) in drug development helps in gaining a deep insight into how real-world data and experiences come together to shape impactful pharmaceutical solutions. Introduction to […] The post The Role of Real-World Evidence (RWE) in Drug Development: ProRelix Research Insights appeared first on ProRelix Research.
Perficient: Drug Development
FEBRUARY 25, 2024
In this Blog Post we will see methods of writing Spark DataFrame into tables and creating views, for essential tasks for data processing and analysis. Before diving into this blog have a look at my other blog posts discussing about creating the DataFrame and manipulating the DataFrame. Creating DataFrame: [link] Manipulating DataFrame: [link] Dataset: The Below is the Dataset that we will be using for looking on writing into a table and create views from DataFrame.
Expert insights. Personalized for you.
129 
Let's personalize your content